Overview
Lupin Ltd is a multinational pharmaceutical company based in Mumbai, India. It operates primarily in the pharmaceutical industry, focusing on branded and generic drugs, biosimilars, and complex generics. Lupin is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective, and NSAID spaces and also has a robust pipeline in Dermatology, Respiratory, and Oncology. The company is recognized for its work in tuberculosis treatment and is also involved in various key projects, including the development of complex generics and biosimilars, which are expected to drive future growth. Lupin's mission is to become a transnational pharmaceutical company through the development and introduction of a wide range of branded and generic formulations as well as Active Pharmaceutical Ingredients globally.
Basic Stats
The share price of Lupin Limited as of 2 May 2025 is ₹ 2,057.80 / share. The market cap (or net worth) of Lupin Limited as of 5 September 2025 is ₹ 939,519.55 MM.
The Factor Analysis chart (below right) shows a view of Lupin Limited from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | 939,519.55 MM |
| EV | 962,719.85 MM |
| Shares Out. | 456.57 MM |
| Earnings Date | |
| EPS (TTM) | 81.03 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-07-25 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | 0.25 |
| Beta | 0.52 |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | 25.40 |
| Price/Book | 5.43 |
| Price/TBV | 7.53 |
| Book/Market | 0.18 |
| EBIT/EV | 0.05 |
| EBIT(3yr avg)/EV | 0.03 |
| ROA | 0.15 |
| ROE | 0.26 |
| ROIC | 0.16 |
| CROIC | 0.02 |
| OCROIC | 0.13 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 42.94 /100 |
| Profitability | 77.70 /100 |
| Quality Score | 76.59 /100 |
| Value Score | 53.72 /100 |
| Momentum Score | |
| Stability (Low Vol) Score | 81.23 /100 |
| Analyst Sentiment | |
| Fund Sentiment | 25.73 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 5.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Lupin Limited is ₹ 2,263.95. The forecasts range from a low of ₹ 1,479.58 to a high of ₹ 2,753.42. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Lupin Limited. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2021-08-12 | HDFC Securities | Sell | Maintains | |
| 2021-08-12 | ICICI Securities Limited | Hold | Maintains | |
| 2021-06-15 | Prabhudas Lilladher | Accumulate | Maintains | |
| 2021-05-14 | Axis Direct | Buy | Maintains | |
| 2021-05-14 | ICICI Securities Limited | Hold | Maintains | |
| 2021-05-14 | Motilal Oswal | Neutral | Maintains | |
| 2021-05-14 | Nirmal Bang Institutional | Accumulate | Maintains | |
| 2021-05-14 | HDFC Securities | Accumulate | Maintains | |
| 2021-05-14 | Prabhudas Lilladher | Accumulate | Maintains | |
| 2021-01-30 | HDFC Securities | Buy | Maintains | |
| 2021-01-29 | ICICI Securities Limited | Buy | Maintains | |
| 2021-01-29 | BOB Capital Markets Ltd. | Accumulate | Maintains | |
| 2021-01-29 | Nirmal Bang Institutional | Accumulate | Maintains | |
| 2021-01-29 | Prabhudas Lilladher | Buy | Maintains | |
| 2021-01-12 | Axis Direct | Buy | Maintains | |
| 2020-11-06 | Prabhudas Lilladher | Buy | Maintains | |
| 2020-11-06 | ICICI Securities Limited | Hold | Maintains | |
| 2020-11-06 | Motilal Oswal | Buy | Maintains | |
| 2020-11-06 | Nirmal Bang Institutional | Buy | Maintains | |
| 2020-11-06 | HDFC Securities | Buy | Maintains | |
| 2020-09-30 | Prabhudas Lilladhar | Buy | Maintains | |
| 2020-09-30 | Prabhudas Lilladher | Buy | Maintains | |
| 2020-08-12 | Geojit BNP Paribas | Sell | Maintains | |
| 2020-08-11 | KRChoksey | Buy | Maintains | |
| 2020-08-10 | Karvy | Sell | Maintains | |
| 2020-08-10 | Nirmal Bang Institutional | Buy | Maintains | |
| 2020-08-10 | HDFC Securities | Buy | Maintains | |
| 2020-08-08 | BOB Capital Markets Ltd. | Accumulate | Maintains | |
| 2020-07-26 | Dolat Capital | Sell | Maintains | |
| 2020-07-02 | Karvy | Sell | Maintains | |
| 2020-06-05 | BOB Capital Markets Ltd. | Accumulate | Maintains | |
| 2020-06-04 | BOB Capital Markets Ltd. | Sell | Maintains | |
| 2020-06-01 | Karvy | Sell | Maintains | |
| 2020-06-01 | Nirmal Bang Institutional | Buy | Maintains | |
| 2020-06-01 | HDFC Securities | Results Update | Maintains | |
| 2020-05-31 | ICICI Securities Limited | Hold | Maintains | |
| 2020-05-30 | Motilal Oswal | Buy | Maintains | |
| 2020-05-30 | Prabhudas Lilladhar | Buy | Maintains | |
| 2020-05-30 | Prabhudas Lilladher | Buy | Maintains | |
| 2020-05-10 | Prabhudas Lilladhar | Buy | Maintains | |
| 2020-05-10 | Prabhudas Lilladher | Buy | Maintains | |
| 2020-04-20 | ICICI Securities Limited | Hold | Maintains | |
| 2020-02-19 | Geojit BNP Paribas | Sell | Maintains | |
| 2020-02-11 | ICICI Securities Limited | Hold | Maintains | |
| 2020-02-07 | Nirmal Bang Institutional | Accumulate | Maintains | |
| 2020-02-07 | HDFC Securities | Neutral | Maintains | |
| 2020-02-07 | Prabhudas Lilladher | Reduce | Maintains | |
| 2020-02-06 | Motilal Oswal | Buy | Maintains | |
| 2019-12-19 | Prabhudas Lilladhar | Hold | Maintains | |
| 2019-11-26 | Nirmal Bang | Accumulate | Maintains | |
| 2019-11-13 | Prabhudas Lilladher | Hold | Maintains | |
| 2019-08-09 | Prabhudas Lilladher | Reduce | Maintains | |
| 2019-08-08 | Karvy Stock Broking | Hold | Maintains | |
| 2019-07-19 | Edelweiss | Buy | Maintains | |
| 2019-05-17 | HDFC Securities | Buy | Maintains | |
| 2019-05-16 | Prabhudas Lilladher | Reduce | Maintains | |
| 2019-05-16 | ICICIdirect.com | Hold | Maintains | |
| 2019-05-16 | Karvy Stock Broking | Hold | Maintains | |
| 2019-05-16 | Reliance Securities | Reduce | Maintains | |
| 2019-04-25 | Elara Capital | Sell | Maintains | |
| 2019-04-24 | Kotak Securities | Reduce | Maintains | |
| 2019-02-11 | HDFC Securities | Buy | Maintains | |
| 2019-02-08 | Reliance Securities | Hold | Maintains | |
| 2019-02-08 | ICICIdirect.com | Hold | Maintains | |
| 2019-02-07 | Motilal Oswal | Buy | Maintains | |
| 2018-10-31 | Prabhudas Lilladher | Reduce | Maintains |
